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Introduction
The dystrophin gene is the largest in the genome: at approximately 2.4Mbp in length this single gene accounts for almost 0.1% of human haploid DNA and occupies fully 1.5% of the X chromosome where it resides. Transcription of a single full-length 79-exon dystrophin mRNA is estimated to take 16 hours, with translation giving rise to dp427 dystrophin (a protein product of 427kDa). This lengthy gene also displays unconventional transcriptional behaviour: the dp427 transcript can arise from three separate promoters controlling cortex, muscle and Purkinje cell expression, producing dp427c, dp427m and dp427p respectively (1, 2) . Each promoter confers a unique first exon but the other 78 are shared, resulting in dp427 proteins essentially identical in sequence, differing only in the first 3-11 amino acids (of a total of almost 3700). The dystrophin gene also carries several internal promoters producing shorter transcripts, generating multiple Nterminally truncated protein isoforms (similarly named by molecular weight, thus dp260 (3), dp140 (4), dp116 (5) , and dp71 (6)): see Figure 1A . These isoforms show clear tissue-specific expression patterns and likely play unique cellular roles, but most studies to date have focussed on dp427m, the full-length muscle isoform: mutations almost anywhere in the dystrophin gene affect this isoform, and this isoform is critical to human health.
Dp427m is the only dystrophin isoform expressed in skeletal muscle (7) , and the long dp427 protein it encodes contains three principal domains: an N-terminal actin-binding region, a C-terminal dystroglycanbinding region, and a lengthy 'rod' domain of 24 spectrin-like repeats linking the two ( Figure 1B) (8) . This protein localizes to the sarcolemma ( Figure 1C ) where it forms a key component of the dystrophinassociated glycoprotein complex (DAGC), localizing proteins that aid muscle function such as neuronal nitric oxide synthase (nNOS) (9) and acting as a physical link between the intracellular actin cytoskeleton and the extracellular matrix environment (10) . Insufficient or absent muscle dp427 ( Figure 1D ) results in weakness of the muscle sarcolemma, leaving muscle fibres vulnerable to contraction-induced injury, leading to the incurable and fatal muscle-wasting disease, Duchenne muscular dystrophy (DMD). This X-linked disease, affecting 1 in 5000 new born boys (11, 12) , is characterized by cycles of muscle degeneration and compensatory regeneration, with concomitant persistent inflammation and progressive loss of muscle tissue to fat and fibrotic scarring: boys become wheelchair-bound between the age of 8 and 12, and death typically occurs in the 20s-30s via either cardiac or respiratory failure (13) . Mutations that cause premature termination of dp427 result in DMD, however mutations that cause in-frame internal truncation of dp427 typically lead to the milder condition, Becker muscular dystrophy (BMD), suggesting that while N and C termini are critical for function, the rod domain is largely dispensable: indeed, use of antisense oligonucleotides to mask splicing sites in the dp427 pre-mRNA leads to omission of targeted exons in DMD-causing transcripts and consequent restoration of reading frame, offering a means to change DMD to a BMD phenotype. These 'exon-skipping' approaches represent a promising therapeutic approach.
Dystrophin remains a challenging target of investigation: dp427 represents only a tiny fraction of total muscle protein (~0.002% (14) ), and levels of transcripts within skeletal muscle are consequently similarly modest (15, 16) . Immunohistochemistry with specific antibodies allows the subcellular localization of dystrophin protein to be determined with high accuracy, but similar studies at the mRNA level are more challenging. In-situ hybridization (ISH) with biotinylated (17) or radiolabelled (18) probes suggests a sarcolemmal localization of the dp427 transcript, but further details are confounded by the innate limitations of this technique and the low transcript abundance. Most studies of dp427 mRNA dynamics have therefore typically measured dystrophin expression in whole muscle extracts, necessarily discarding spatial information. As muscle tissue is host to multiple cell types (19) , such approaches also introduce unavoidable noise (a problem exacerbated in dystrophic muscle where infiltrating inflammatory cells, fibroblasts, adipocytes and differentiating myoblasts further diversify the cellular milieu (20) ). Despite these limitations, pioneering work by Tennyson et al (21) determined estimates for dp427 transcription time of the order of 16 hours, and showed that splicing occurred co-transcriptionally (work subsequently supported by others investigating transcription of long genes (22) where co-transcriptional splicing and elongation rates of bases per second were reported). Further investigations (16) suggested that in human muscle dp427 5' sequence was present in excess of 3' sequence (i.e. nascent transcripts exceeded mature), suggesting the half-life of mature dp427 might be modest, but at the time such work necessitated transcript estimation via somewhat crude RT-PCR autoradiography. An elegant recent study by Gazzoli et al revealed that cotranscriptional splicing of dp427 occurs non-sequentially, and that long introns in particular (several are >100kb) are spliced in multiple steps (23) , however most studies of dp427 focus on disease-or therapeuticrelevant metrics such as the efficiency of exon-skipping (percentage of skipped transcripts) rather than more general properties of the mRNA itself (particularly at the histological level). Recent technological advances such as RNAscope (24) have led to a resurgence in ISH-based investigations, suggesting that detailed study of muscle dp427 mRNA at the histological level might now not only be practical, but also (given the large size and low abundance of the transcript, and the unique multinucleate nature of myofibres) highly nuanced.
The RNAscope ISH approach employs proprietary 'ZZ' oligonucleotide probe pairs: each probe carries 18-25 bases of target-complementary sequence linked to one half of a preamplifier-binding motif. The preamplifier carries multiple amplifier-binding motifs, and the amplifiers in turn are able to bind peroxidase enzymes in very high local concentrations. Use of 20 such ZZ pairs in series allows targeting of ~1000 bases of target sequence (rendering this method highly specific), and use of the amplification strategy with peroxidase-activated tyramide dyes affords very high sensitivity, allowing detection of individual mRNA transcripts with sub-cellular resolution (Figure 2A -E). Crucially, this technique can also be multiplexed: by use of probe-specific amplifiers and sequential labelling, multiple mRNA species can be resolved, each with a different fluorophore ( Figure 2F ). Our approach is a further refinement of this method: we reasoned that the substantial size of the full-length dystrophin transcript would readily permit multiple 20ZZ probe sets to bind to the same mRNA, a hypothesis supported by Smith et al, using conventional fluorescent probes (25) to resolve the nascent transcriptional locus within cultured myonuclei. Using probes targeted to 5' and 3' sequence of dp427 (see Figure 1A ) offers an elegant means to label transcripts in a temporal fashion (in a manner similar to that first used by Garcia et al (26) , but without recourse to complex transgenics), and should permit unprecedented resolution of individual mature and nascent dystrophin mRNA molecules within skeletal muscle: nascent transcripts would bind 5' only, while mature would bind both ( Figure 2G ).
Here, we have used these probes in healthy and dystrophic (mdx) mouse muscle and in mdx muscle rescued with exon-skipping agents to reveal remarkable insights into the localization and dynamics of this critical transcript in health and disease. Our work supports the findings of previous investigations while adding valuable spatiotemporal refinements unachievable by other means, and suggests that this approach offers a powerful and versatile new tool not only for the study of dystrophin, but for other transcripts produced from long genes.
Methods

Probe design
20ZZ RNAscope probes (ACDBio) were designed to mouse dystrophin sequence (accession number NM_007868.6). The catalogue probe (Mm-Dmd, Cat. No. 452801) recognizes residues 320-1295 (exons 2 to 10) of the full-length (dp427) dystrophin transcript. This probe (henceforth: 5' probe) recognizes fulllength dp427 only, but will bind both nascent and mature dp427 transcripts. A further custom probe (Mm-Dmd-O1, henceforth: 3' probe) was designed to residues 9581-10846 (exons 64-75). This 3' probe hybridizes to sequence emerging late in transcription, favouring mature transcripts. Given shared sequence, 3' probe will recognize essentially all dystrophin isoforms (dp427, 260, 140, 116, 71 -see figure 1A ).
Positive control probes to POLR2A (NM_009089.2, residues 2802-3678), PPIB (NM_011149.2, residues 98-856) and UBC (NM_019639.4, residues 36-860) were used to confirm preservation of sample RNA, while negative control probes to bacterial DapB (EF191515, residues 414-862) were used to establish nonspecific labelling.
Sample preparation
Animals: Seven 40-week old male mice (3 mdx and 4 wild-type C57BL/6J -referred to within the text as mdx 1-3 and WT 1-4) bred under UK Home Office Project Licence PPL 70/7777 were killed by cervical dislocation, with tissues harvested rapidly post mortem. Quadriceps muscles from a further three 32-week old male mdx mice (untreated -mdx 4 within the text-, or treated intravenously with PIP6a peptideconjugated antisense morpholino oligonucleotide (PPMO) at 6mg.kg -1 and 12.5mg.kg -1 ) were archive samples taken from two separate studies ((27) and manuscript in preparation). Briefly, mice were treated via tail vein injection with the PPMO starting at 12 weeks of age, continuing for a total of 10 injections each separated by two weeks with collection two weeks after the last dose. Quadriceps muscles were mounted longitudinally (a configuration that generates longitudinal and transverse regions within a single section) in cryoMbed mounting medium (Bright instruments Ltd) and flash-frozen in liquid N 2 -cooled isopentane.
Freezing in an essentially relaxed configuration rather than pinned out to L0 reduces fibre hypercontraction immediately post-sectioning (see below).
Cryosectioning: muscle tissues were sectioned at -25°C to 8μm thickness using an OTF5000 cryostat (Bright) and mounted on glass slides (SuperFrost, VWR). Preparation of longitudinal sections from frozen mouse muscle is non-trivial: transient melting during transfer of section to slide typically results in considerable fibre hypercontraction as contractile proteins respond to abundant free calcium ions.
RNAscope ISH involves multiple detergent washes and incubations at 40°C, necessitating the enhanced tissue affinity of SuperFrost slides, but this slide format is incompatible with EDTA-coating methods of Pearson and Sabarra (28) . It was determined that freezing muscles in a relaxed state and sectioning at 8 micron thickness generates acceptable longitudinal sections without the requirement for EDTA: at this thickness, shear forces generated by contractile proteins in the presence of free Ca 2+ appear largely insufficient to overcome the rapid adhesion to SuperFrost slides. Serial sections were collected and slides were air-dried at -20°C for 1 hour before storage at -80°C until use.
Staining
Immunofluorescence: slides were allowed to equilibrate to room temperature, blocked for 1hr using 5% milk powder (Marvel) in PBS + 0.05% tween (PBS-T), and then co-immunolabelled with rabbit polyclonal antidystrophin (ab15277, Abcam, 1:800) and rat monoclonal anti-perlecan (clone A7L6, Thermofisher, 1:2000), in PBS-T for 1hr. Secondary labelling used Alexa-fluor conjugated antibodies (anti-rabbit 488 and anti-rat 594 respectively, Thermofisher, both 1:1000, 1hr). Nuclei were stained using Hoechst 33342 (Thermofisher, 1:2000, 10 minutes), and slides were then washed and mounted using Hydromount (National Diagnostics). SDH: slides were allowed to equilibrate as above, then incubated with freshly-prepared SDH staining solution (125mM sodium succinate, 1.5mM nitroblue tetrazolium, 60mM Tris HCL, pH 7.0) at 37°C for 1 hour, fixed in formal calcium for 15mins at room temperature, then washed and mounted in Hydromount.
RNAscope slide preparation
The combination of protease digestion and detergent-rich wash buffer used by RNAscope is incompatible with fresh-frozen muscle prepared according to standard protocols: while connective tissue/extracellular matrix elements (and most nuclei) were readily retained throughout the protocol, myofibrillar content was rapidly lost leaving empty myofibre 'ghosts' (see Supplementary Figure S1 ). Preparation of frozen muscle thus required extended fixation and an additional baking step (both indicated with an asterisk): slides were removed from -80°C storage and placed immediately into cold (4°C) 10% neutral-buffered formalin, then incubated at 4°C for 1 hour*. Slides were then dehydrated in graded ethanols (50%, 70%, 100% x2, 5mins in each, room temperature) and left in 100% ethanol at -20°C overnight, then air-dried and baked at 37°C for 1 hour*. Sections were ringed using hydrophobic barrier pen (Immedge, Vector Labs) and then treated with RNAscope hydrogen peroxide (ACDbio) for 15mins at room temperature to quench endogenous peroxidase activity. After washing twice in PBS, slides were protease-treated (RNAscope Protease IV, ACDbio) for 30mins at room temperature and washed a further two times in PBS before use in RNAscope multiplex assay (see below).
RNAscope multiplex assay
Multiplex assays were performed according to the manufacturer's protocols. All incubations were at 40°C and used a humidity control chamber (HybEZ oven, ACDbio). Probe mixes used were as follows:
• RNAscope 3-plex positive control probe set (320881): POLR2A, PPIB and UBC (low, moderate and high expression targets supplied as C1, C2 and C3 probes, respectively)
• RNAscope 3-plex negative control probe set (320871): Bacterial DapB (in C1, C2 and C3 probe sets)
• RNAscope mouse dystrophin probe set: Mm-Dmd (452801) and Mm-Dmd-O1 (custom probe) (C1 and C2 probes, respectively).
Tyramide dye fluorophores (FITC, Cy3, Cy5: TSA plus, Perkin Elmer NEL760001KT) were used diluted appropriately in RNAscope TSA dilution buffer. Nuclei were labelled with RNAscope DAPI (ACDbio) for 30 seconds, or Hoechst (1/2000 in wash buffer for 10mins followed by two washes). Slides were mounted in Prolong Gold Antifade mounting medium (Thermofisher).
Positive and negative control slides were typically given the following fluorophore assignments: C1 -TSA-FITC; C2 -TSA-Cy3; C3 -TSA-Cy5. Due to weak FITC fluorescence and strong signal intensity of the 5' dystrophin probe (as compared with the 3' probe), many combinations of fluorophore posed either poor probe comparability or signal bleed-through (particularly those using TX2 filter cubes). Our preferred final fluorophore combination for dystrophin was therefore TSA-Cy3 and TSA-Cy5 (for C1 5' and C2 3', or switched as indicated). Used with the N3 and Y5 filter cubes, this combination of fluorophores had no signal overlap and allowed selection of modest exposure times without bleed-through. TSA dyes were used at the following dilutions: TSA-FITC, 1/500; TSA-Cy3, 1/1500; TSA-Cy5, 1/750.
Imaging
Individual images were collected using either a DM4000B or DMRA2 upright fluorescence microscope with samples illuminated using an EBQ100 light source and A4, L5, N3 and Y5* filter cubes (Leica Microsystems) and an AxioCam MRm monochrome camera controlled through Axiovision software version 4.8.2 (Carl Zeiss Ltd). For all analysis, images were captured via 20x objectives (20x HC PL FLUOTAR PH2, NA=0.5) which readily enabled identification of discrete foci corresponding to individual transcripts, while retaining sufficient axial resolution to allow all elements of the tissue section to remain well-focussed.
Multiple images were collected per muscle section, selected randomly (avoiding section tears and tendinous regions). For particle counts, exposure times were calculated to allow clear detection of small foci in all channels (typically 600-1500msec). For fluorescence intensity (3-5 images per muscle section), multiple exposure times were collected (100-1000msec) to minimize risk of signal saturation. For whole section alignments, images were collected at 5x and stitched using the pairwise-stitching algorithm of Preibisch et al (29) . After analysis, images shown in figures were adjusted for clarity using the window/level tool (imageJ).
Image analysis
Collected images (as tiff format files) were analysed using ImageJ, using automated macros (all requisite .ijm files can be provided on request). In brief, images were separated into Cy5, Cy3 and DAPI channels:
for counts of nuclei, nuclear stain was thresholded automatically using either Huang or Yen's algorithm (30) and given a single binary watershed pass to separate adjacent nuclei. Cy3 and Cy5 channels were thresholded to eliminate background/non-specific staining and foci were counted using the 'Analyze Particles' tool. Fluorescence microscopy cannot reveal the true size of fluorescent particles (instead resolving a point-spread function (31)) but apparent size allows discriminatory analysis: apparent particle areas were converted to square microns using the appropriate multiplier for the magnification and image resolution. For nuclear/extranuclear particle analysis, the DAPI channel was thresholded as above and applied as a mask to the Cy3/Cy5 channels (eliminating nuclear-localized signal) or applied as an inverted mask (eliminating non-nuclear signal) prior to thresholding and particle counting. Nearest neighbour analysis used extranuclear foci only (distributions for random points were obtained from the average of ~1000 virtual fields of randomly-generated points of specified total number). Due to stark differences in 5' signal intensity, 5' probe fluorescence intensity analysis used images (3-5 per animal) collected at multiple exposure times (see above): regions of interest (sharply-defined small foci, broad nuclear probe signals, and background regions; 30-50 per image, 10-15 for background) were determined from the highest exposure, then quantified at lower exposure times using only non-saturated signal.
Calculations
Mean values of transcripts per field were used to calculate total transcript numbers via the following calculations: 1388x1040 pixel imaging field at 20x (~2 pixels per micron) = 360880μm 2 at a section 1 0 thickness of 8um, thus 2889040μm 3 (2.9x10 -3 mm 3 ). At a muscle density of 1.06g.ml -1 (32), a single imaging field thus represents ~3μg of tissue. Typical RNA yields per mg of muscle tissue are 0.25-0.5μg, thus a single 20x imaging field can be considered to contain 0.75-1.5ng of total RNA.
Calculation of transcript half-lives:
Half-life calculations used the method provided by Tennyson and colleagues (16) . At steady-state, the ratio of 5' sequence (nascent and mature dp427) to 3' sequence (mature only) represents the balance of transcription time to mean lifetime.
The half-life of a given species is related to the mean lifetime by the equation T lifetime = T 1/2 /0.693.
Our 5' probe sequence ends at exon 10 and the 3' at exon 74 (1550kbp between the two) while our qPCR regions (see below) were designed to the exon 1:2 and exon 62:63 boundaries (1950kbp); assuming 16 hour constant-rate transcription for full-length dp427 (21) this gives an approximate transcription time between 5' and 3' of ~11 hours for RNAscope probe regions and 13.5 hours for qPCR amplicon regions.
RNA isolation and qPCR
cDNAs used for qPCR (male quadriceps muscle, 9 WT, 9 mdx) were archive samples from our collection.
Isolation and preparation methods were as described previously (33, 34) : RNA was isolated from muscle powder (homogenized under liquid nitrogen) using TRIzol reagent (Invitrogen) with inclusion of an additional chloroform extraction (1:1) after phase separation. RNA was assessed to determine yield and purity (nanodrop ND1000) and used to prepare cDNA via RTnanoscript2 (Primerdesign). Triplicate qPCRs used 10μl volumes (~8ng cDNA per well assuming 1:1 conversion) in a CFX384 lightcycler using PrecisionPLUS SYBR green qPCR mastermix (Primerdesign), with a melt curve included as standard.
Primers to ACTB, RPL13a, CSNK2A2 and AP3D1 (reference genes determined previously (33)) were taken from the geNorm and geNorm PLUS kits (Primerdesign). Primers to dystrophin dp427 and dp71 were 
Results
In situ hybridization reveals 5' and 3' sequences of dp427 mRNA show non-identical distributions, and allows detection of nascent and mature transcripts
RNAscope in-situ labelling allows resolution of individual mRNA molecules, particularly when used with low-abundance transcripts (24) , and the expected staining pattern is that of small, punctate foci with an apparent diameter of 1-1.5μm distributed throughout the cell interior. Muscle labelled with positive control probes (to Polr2a, Ppib and UBC: very low, low and high-expression in skeletal muscle, respectively (35)) behaved consistently with these expectations (Supplementary Figure S2 A closest to the sarcolemma), but also a second, less-numerous population of broad, heterogeneous and highintensity signals localized exclusively to specific nuclei. The intensity of this latter population was such that these large 5' foci were readily detectable even at low magnification. 3' probe signal displayed essentially only the former punctate signal, both within nuclei and without; notably, these foci were typically found adjacent to 5' foci. These distributions were consistent throughout the entire muscle section, both in transverse and longitudinal fibres, and reciprocal patterns were observed if the fluorophores chosen were exchanged (i.e. signal intensity and localization is a property of the probes alone: Supplementary Figure S3 ).
Given co-transcriptional splicing (21) , target sequence for the 5' probe should emerge and persist early in transcription, while 3' sequence should appear only shortly before mRNA completion and nuclear export.
Intense nuclear staining for 5' sequence (but not 3') implies not only that nascent dp427 transcripts can readily be detected by our approach, but that multiple nascent transcripts are present within any given nucleus. The smaller foci (both 5' and 3') found outside nuclei would thus represent dual-labelling of mature dp427 transcripts. Supporting this, labelling of dystrophic mdx muscle with our probes (Figure 4 ) revealed key differences to healthy muscle: prominent 5' nuclear foci were readily detected, but smaller punctate foci from both probe sets were much less prevalent and almost exclusively found within (or adjacent to) nuclei.
RNAscope labelling of dp427 mRNA permits transcript quantification at subcellular levels
The well-defined foci produced by RNAscope labelling are amenable to semi-automated image analysis approaches, allowing measurement of both particle number and apparent area. As shown in Figure 5A and Table 1 , healthy muscle particle counts were significantly higher than those for dystrophic muscle for both 5' and 3' probes. Per-image variation was however notable even within a given muscle section (Supplementary Figure S4A ) and we speculated this might correlate with fibre type or myofibre nuclear number. Alignment of images with SDH-stained serial sections revealed a correlation between particle count and SDH activity (i.e. oxidative fibres might express higher levels of dp427) however these regions were also host to greater numbers of nuclei, and particle counts correlated better with nuclear number than with SDH (Supplementary Figure S4B -D), suggesting this is the principal source of within-section variation.
Normalizing counts to nuclei would bias against dystrophic muscle (nuclear counts are significantly higher in this tissue: Supplementary Figure S4E ), thus all analyses below used non-normalized, per-image counts.
Despite marked differences in total count, healthy and dystrophic muscle exhibited similar distributions of apparent particle size ( Figure 5B ): signal from the 3' probe was near-exclusively comprised of foci 1-2μm 2 in area while 5' probe signal could instead be segregated into two discrete populations, one of small foci similar to 3' probe, and a second, larger and more heterogeneous population spanning 10-100μm 2 . We designated particles with areas between 0.5 and 10μm 2 as 'small foci' (95% of this population fell between 1-3μm 2 ) and those of 10-100μm 2 as 'large foci'. Segregated by these criteria ( Figure 5C and Table 1 ), counts of large 5' foci were comparable between healthy and dystrophic muscle: differences in 5' particle number were entirely due to smaller foci. The unique multinucleate structure of myofibres permitted further segregation by subcellular distribution (nuclear or sarcoplasmic, Figure 5D and E), refining this analysis and confirming that large 5' fluorophore deposits were indeed restricted to nuclei, while smaller foci (5' and 3') were found in both nuclear and sarcoplasmic compartments. Crucially, only the sarcoplasmic fractions of these small foci had reduced counts in dystrophic muscle: numbers of small foci within nuclei showed no reduction.
600-1400 sarcoplasmic foci were found in every healthy muscle image (10-20% within nuclei) compared with 100-300 in dystrophic muscle (50-60% nuclear). Large 5' nuclear foci were present in lower numbers (50-100 per image in both healthy and dystrophic muscle), comprising only 6-12% percent of particles in healthy muscle (20-30% of nuclei) but accounting for 30-50% of total dystrophic counts (10-15% of nuclei due to the higher per-image nuclear count: Supplementary Figure S4E ). for random distributions (<1%). As shown in Figure 6 , in healthy muscle almost 40% of all foci can be paired within this distance (whether 5' to 3' or the reverse), and of the remaining foci, minimum distances below 8μm are over-represented: pairings below 4μm were more common than would be expected even for 1400 random points (double the mean number of observed WT sarcoplasmic foci: see Supplementary Figure   S5E ). Conversely, the distribution of minimum distances in dystrophic muscle was more consistent with random chance, suggesting that the majority of sarcoplasmic foci (already low in number at ~100-200 per image) found in this tissue do not represent mature dp427 mRNAs (30-40% of foci were more than 30μm
5' and 3' probes co
from an opposing focus, as seen with low numbers of random points: see Supplementary Figure S5F ).
Nevertheless, an increased fraction of paired distances below 8μm was observed, along with sub-micron colocalizations at levels approaching 25% in some images. Closer inspection showed these foci were not widely-distributed; instead occupying small fibre-restricted domains exhibiting local sarcoplasmic 5'/3' counts comparable to healthy muscle. We conjectured these might correspond to corrected dp427 transcripts expressed within sporadic dystrophin-positive revertant fibres (36) . Alignment with serial sections immunolabelled for dystrophin protein (Figure 7) showed that regions of dp427 probe labelling do indeed correspond to revertant fibres. RNAscope images collected only from regions aligning with revertant fibres showed higher mean sarcoplasmic 5' counts than images collected randomly, though the increase was not uniform: some regions of revertant fibres showed no concomitant increase in probe labelling, implying that domains of dp427 mRNA might be more focal than those of dp427 protein.
Taken together, these observations support our interpretations: sharp, punctate foci outside the nuclear envelope -with 5' and 3' probe signals found in close apposition-are consistent with mature, exported dp427 mRNA molecules. Conversely, strong but less well-defined fluorescence restricted to the 5' probe and found only within the nuclear compartment is consistent with labelling of immature transcripts.
Concomitantly, only mature, exported dp427 signal shows profound reduction in dystrophic muscle: dp427 mRNA produced by mdx mice carries a premature termination codon (PTC) in exon 23 (37) and is subject to nonsense-mediated decay (NMD) (38) , a checkpoint that occurs only after nuclear export (39) .
Quantification of nascent and mature transcripts shows mature dp427 mRNA is short-lived
As large nuclear foci represent nascent mRNA, an additional source of quantitation is offered by This data, combined with the counts of mature dp427 mRNA molecules above, allows estimation not only of total dystrophin expression, but also of the distribution of such expression between mature mRNA molecules and transcripts in progress ( Figure 8B ). Immature transcripts naturally comprise the bulk of signal in dystrophic muscle, but even within healthy muscle, prominent nuclear 5' foci represent ~10% of the total 5' signals: with each dp427-expressing nucleus host to 20-40 immature transcripts, the implication is that under normal healthy conditions nascent transcripts account for 60-80% of total dp427 mRNA.
We corroborated these estimates by quantitative RT-PCR (qPCR) targeted to specific 5' or 3' regions of the dystrophin gene: using primers spanning the exon:exon junctions at 1-2, 44-45 and 62-63, and quantifying absolute transcript numbers, we show that numbers of detected transcripts decline as expected as the target sequences approach the 3' terminus, but in dystrophic muscle even 5' signal is reduced, with transcripts containing exons 62-63 being reduced yet further (to levels approaching zero). As shown ( Figure 8C ) qPCRderived transcript numbers also agreed closely with those obtained via RNAscope both for healthy and dystrophic samples, and confirmed that even in healthy muscle the bulk of dp427 is immature. This marked ~3-4-fold bias toward incomplete transcripts, combined with the estimated 16-hour transcription time for a single dp427 mRNA, suggests that once completed and exported, a mature dystrophin transcript has an average lifespan of only ~3.5 hours (see methods), substantially shorter than the time invested in its synthesis.
RNAscope in situ hybridization permits quantification of dystrophin induction via exon skipping
To investigate whether dp427 probes could be used to assess therapeutic efficacy, we examined muscle RNAscope probes. As shown in Figure 9 , lower dose treated muscle was essentially indistinguishable from untreated mdx muscle, but sarcoplasmic counts of both 5' and 3' foci in muscle treated with a higher dose were comparable to WT counts (and had concomitant restoration of 5'-3' co-localization not seen with lower dose treatment: compare Supplementary Figures S7A and B) . In high dose treated muscle, the fraction of nuclei with large 5' foci was also restored to WT levels (25-30%) and nuclear 5' signal was similarly more intense, yet numbers of nuclei per field remained elevated (comparable with untreated mdx, see Supplementary Figure S7C ), with the corollary that all nuclear counts (5' small/large and 3' small) were higher than those of WT muscle.
Discussion
Resolution of mRNA molecules by in-situ hybridization has historically faced a number of challenges:
abundant transcripts can be detected relatively easily, but useful quantitative and spatial expression data is often lost in the consequent wash of strong signal. Conversely, low abundance transcripts might well lend themselves to more nuanced analysis, but cannot usually be detected with significant confidence to allow such analyses. Furthermore, most ISH methods are either radiometric or colorimetric, and thus cannot easily be multiplexed. The in-situ fluorescence amplification methodology of RNAscope ZZ-probes offers high sensitivity and multiplexing (24) , adding a valuable tool for histological study of gene expression in health and disease. Although widely used for multiple mRNA species within a tissue, to our knowledge the data shown here represents the first use of this technology to visualize multiple probes within a single transcript.
Even with ~1000 base hybridization sequences, the ~14,000 base dp427 transcript readily permits multiple probes to anneal; since expression is low, individual mature transcripts can readily be resolved as discrete entities. The enormous genomic DMD locus (~2.3Mbp, with 16-hour transcription time) further allows temporal metrics to be assessed, with strong 5' probe labelling revealing nascent transcripts. Our work thus demonstrates a new use of RNAscope multiplexing that is particularly suited to long mRNAs transcribed from large genomic loci, allowing the identification of transcriptional subtleties that would otherwise remain intractable. Given that the DMD gene has key disease-relevance with many therapeutic approaches directed at the transcript level, our method is particularly suited to its study.
Subcellular localization of mature dp427 mRNA
We show that individual mature dp427 mRNAs can be detected within the muscle sarcoplasm, binding both 5' and 3' probes in close proximity as expected. These mature transcripts are essentially absent in dystrophic muscle, yet comparatively high numbers (binding both probes) can still be found in rare patches that align with dystrophin immunoreactive revertant fibres. Previous in-situ studies of dystrophin dp427 expression have suggested that in healthy muscle this transcript preferentially localizes to the sarcolemma (17) . Such a subcellular location is biologically plausible: the full-length dystrophin protein resides immediately beneath the sarcolemma, and this protein is moreover very large (427KDa in size) and carries multiple proteinbinding domains. A single mRNA is relatively compact and can give rise to multiple protein molecules:
targeting dp427 mRNA to the sarcolemma before translation would presumably be considerably more efficient than transporting protein post-translationally. The transcript-level resolution offered by our data suggests that this is largely correct: we have endeavoured to capture both longitudinal and transverse muscle sections, and while in both orientations mature dp427 molecules are clearly found throughout the myofiber interior, transcript concentration does indeed appear to be highest immediately beneath the sarcolemma.
Behaviour and quantification of mature dp427 mRNA
The co-localization analysis permitted by our 5'/3' labelling is revealing: under physiological conditions, most messenger RNA is expected to exhibit extensive secondary structure, and to be found as mRNP complexes with RNA binding proteins (40) . This is especially true for mRNA molecules with large 5' and 3'
UTRs (such as dystrophin), and indeed the 5' and 3' termini of such mRNAs are reported to be very closely apposed in most cases (potentially in the order of nanometre separations (41)). Efficient probe hybridization (and subsequent fluorophore labelling) requires conditions far from physiological, however, necessitating significant disruption of mRNP complexes and mRNA secondary structure (via protease treatment and lengthy incubations at supra-physiological temperatures in the presence of salts and detergents). One might therefore expect a significant percentage of transcripts to unfold to some extent, disrupting this colocalization. Despite this, in healthy muscle labelled with our dystrophin probes, ~40% of sarcoplasmic 5' signals were found within a micron of a 3' signal (and vice-versa), strongly suggesting that many transcripts are preserved in their native configuration (and that the physiological state of a mature dp427 mRNA is indeed a condensed complex with 5' and 3' ends in close proximity). The remaining foci were also typically paired within distances shorter than would be expected by chance, raising the possibility that these might represent labelling of unfolded transcripts. Length per base of single-stranded RNA remains contentious (42) , and is further proposed to vary with salt concentration and pH (43), thus we cannot empirically state the maximum permissible separation of probes within a single dp427 mRNA. Measurements of ssDNA however report values of ~0.7nm per base (44) , and using this value would put the length of a mature fulllength dystrophin transcript at ~10μm, with the distance between our 5' and 3' probe binding sites just below 6μm (though ssRNA also adopts highly flexible, worm-like chain behaviour, thus mean 5'-3' distance would be substantially shorter (45)). The size and mobility of the amplifier 'trees' generated by RNAscope ISH is not reported, and deposits of fluorophore (activated tyramides react with tyrosine residues in adjacent proteins) might also extend beyond these limits, but even restricting probe pairings to distances below 6μm would account for ~70% of the observed foci in WT muscle (~80% with a more generous 8μm). The remainder might also reflect limits of axial resolution (foci sufficiently out of focus as to be missed by particle analysis), or dp427 transcripts labelled with one probe but not the other (due to inhibitory secondary structure, masking by protein, or even cleavage of the molecule during sectioning). Our mature mRNA counts might consequently be an underestimate of true numbers, though our corroborating qPCR data suggests any such underestimate is modest. We note that counts of 3' foci were typically higher than those for 5', by a small but consistent amount (50-100), an observation partly explained by the greater ease with which signal from this probe can be collected (unlike 5', all 3' foci are of comparable size and intensity), and concomitantly by the fact that all 3' foci represent single molecules, while 5' foci in mature dp427 mRNAs lying adjacent to nuclei may be lost amidst strong nascent 5' staining. 3' labelling in the absence of adjacent 5' might however also represent labelling of dp71: while not reported to be expressed in muscle fibres themselves, this transcript might nevertheless be found in blood vessel endothelia (46) or proliferating myoblasts (47) , and is detected at low levels within whole muscle tissue homogenates, particularly those from young dystrophic muscle undergoing acute degeneration/regeneration (48) . While our dystrophic muscle samples were taken from older mice (where pathology is established and consequently milder) we do observe rare nuclei with multiple nearby 3' foci yet no 5' labelling (see Figure 4B , lower panels). Dp71 expression measured by qPCR is low but detectable in quadriceps muscle (and comparable between healthy and dystrophic tissue): transcript numbers suggest this mRNA might account for ~50-70 additional 3' foci per 20x image ( Supplementary Figure S8 ).
Behaviour and quantification of nascent dp427 mRNA
The genomic sequence of the dp427 region targeted by our 5' probe (exons 2-10) begins ~190kb downstream from dp427m exon 1 and spans ~525kbp: assuming a constant, sequence-independent transcription rate of ~40bases.sec -1 with concurrent splicing (suggested by the 16-hour transcription time for a 2.3Mb gene, and supported by studies of other long genes (21, 22) ), the first nucleotides of this sequence A simple measurement permitted by this strong 5' nuclear labelling is myonuclear number, a value otherwise difficult to estimate. Muscle is host to a variety of cell types, from blood-vessel endothelia and pericytes/mesoangioblasts to fibroblasts, adipocytes, and the dedicated muscle stem cell population of satellite cells (19, 20) , but only myonuclei should robustly express full-length dystrophin. Our data thus suggest that in healthy muscle, myonuclei comprise 20-30% of the nuclei within a typical non-tendinous region of quadriceps muscle, while in dystrophic muscle this figure is 10-15% (commensurate with the higher fraction of non-myonuclear cell types within the dystrophic muscle environment).
A more nuanced quantification is the estimation of immature dp427 transcripts. human foetal myotubes: this discrepancy was attributed to either differential turnover rates between cultured myotubes and mature muscle, a higher rate of premature termination in mature muscle, or an indication that mature skeletal muscle was not at transcriptional steady-state (samples were collected from human cadavers). Our data, obtained from mouse muscle flash-frozen 2-5 minutes post-mortem, would tend to argue against this latter hypothesis. Relatively high rates of premature termination are certainly plausible: at 2.3 million bases, the dystrophin gene likely tests the limits of RNA polymerase processivity (50) , and some evidence exists for premature termination rates above predicted values (21), but such limits are a function of length, not maturity. It is thus unclear why such rates would differ markedly between myogenic cultures and mature muscle. Dp427 may simply experience a higher rate of turnover in mature muscle: the demand for dystrophin is likely to be higher in nascent myotubes where the contractile environment is being established de novo (unlike mature skeletal muscle where turnover of an existing dystrophin protein pool may be all that is required). Given the gene size, production of dystrophin transcripts could be considered innately wasteful (synthesis of a 2.3Mb pre-mRNA for a final transcript of only 14kb), but further, it seems remarkable that mature muscle myonuclei may indeed dedicate 16 hours to producing a molecule with a mean subsequent lifespan of only 4. Biological systems do however often favour expediency over efficiency, and dp427 transcripts comprise only a tiny fraction of myonuclear mRNAs (several thousand-fold lower than myosin heavy chain mRNA (16) ) thus such waste is likely of little energetic consequence. Post-transcriptional control via mRNA stability in fact offers markedly greater utility than control of transcription itself:
assuming the necessary transcription factors could be mobilized rapidly, any changes in expression based on transcriptional initiation would necessarily incur a 16-hour delay (and a second 16-hour delay to return to basal levels) and this presumes the dystrophin locus is not already at near-maximal transcriptional occupancy. In contrast, changes in mRNA stability can be achieved rapidly via phosphorylation (51), and simply halting degradation of mature dp427 transcripts (leaving transcription unchanged) would double mRNA levels in less than half that time. This wasteful but responsive approach might even be common among large genes: the human genome is host to a number of genes larger than 1Mb (>7 hour transcription times), many of which may need to alter expression over shorter timescales. Dynamic expression of dp427 would readily explain the high sample-to-sample variation reported here and previously (16) , and control via mRNA stability would allow expression to fluctuate over a circadian timescale (as has been suggested (52)).
It would be of great interest to examine the behaviour of our RNAscope probes in damaged (Cardiotoxin or BaCl 2 -treated), regenerating healthy muscle: if stability of transcripts is higher in nascent myotubes one might expect newly regenerated fibres to exhibit markedly higher levels of mature dp427 mRNA (something suggested by early ISH work (18)).
Tennyson et al also derived estimates of 5-10 nascent dystrophin mRNAs per muscle nucleus (16) . Our data here refines this estimate: not all nuclei within a muscle express dystrophin (see above), but those that do are host to 20-40 nascent transcripts at a time. This argues in favour of a concerted commitment to dystrophin expression, and provides further support for a maximized production hypothesis. Rare nuclei nevertheless appear to have lower (2-10) numbers of transcripts, suggesting that dystrophin-expressing nuclei might not all be at steady-state expression levels at any given moment: we cannot rule out a sustained but 'burst-like' stochastic expression programme as is common to many eukaryotic genes (53) (transcription in muscle has been reported to exhibit 'pulsed' behaviour (54)). Transcriptional bursting could result in a number of 'quiescent' myonuclei that do not label with our 5' probe (leading to underestimation of myonuclear fraction), though counts of dp427-expressing nuclei were remarkably consistent between animals, suggesting this is unlikely (Table 1 and figure 5D ).
Dystrophic muscle reveals further nuances: while numbers of mature transcripts are reduced to almost zero as expected, the intensity of 5' probe labelling within myonuclei is also reduced. Similar reductions in total message are seen when measurements are made by qPCR. While it would be easy to dismiss this latter observation as a reflection of the higher cell content and transcriptional diversity within dystrophic muscle (thus fewer total myonuclei), our RNAscope data shows that this reduction in expression extends to the myonuclei themselves. As noted, transcript degradation via NMD occurs only after transcription is complete (39) , thus reduction in nuclear signal is best explained by a lower rate of transcriptional initiation (10-12 nascent transcripts per nucleus, thus one transcript initiated/completed every 60-90 minutes). It has been proposed that as a terminal marker of myogenesis, expression of dystrophin itself drives the myogenic programme to completion: low levels of dystrophin expressed earlier in differentiation help drive greater expression of dystrophin, further promoting terminal differentiation and producing a switch-like feedforward loop (55, 56) . Dystrophic muscle, lacking this driver of terminal myofiber commitment, would thus be held in a permanent state of near-maturation, with concomitantly lower levels of dystrophin transcription and reduced 5' nuclear staining intensity ( Figure 10B ).
Our dp427 probes were also capable of recognizing transcripts associated with revertant fibres: the presence of these sporadic dystrophin-positive fibres within dystrophic muscle has long been recognized (36, 57, 58) , and variably explained. Prevalence of these fibres is influenced by the specific mutation carried (the PTC in exon 23 of the mdx mouse readily lends itself to revertant fibre formation, while the PTC in exon 53 of the mdx 4cv mouse does not (59)), and revertant fibre number also tends to increase with age, clustering in a fashion that implies a clonal origin (60, 61) (skipped transcripts are found even in healthy muscle (62)). 1
Current hypotheses tend to favour a coordinated and somehow focally heritable alteration in splicing patterns rather than mutations at the genomic level (60): our data here do not allow these two proposals to be discerned, and indeed the high nuclear counts in dystrophic muscle makes assignation of revertant expression to a specific nucleus or nuclei essentially impossible, but our data do suggest that revertant fibres exhibit high (near-WT) levels of mature dp427 within relatively restricted domains (as might be expected if transcripts are short-lived). We also show that our probes can be used to assess the efficacy of exon skipping approaches, and that our data closely matches that reported previously via alternative methods while providing additional spatial metrics. Mdx mice treated with PIP6a peptide-conjugated skipping oligo at 6mg.kg -1 show low levels (2-10%) of exon skipping and consequently low induction of dystrophin protein (~15%), while treatment at 12.5mg.kg -1 gave skipping levels as high as 80%, widespread dystrophin protein induction, almost complete protection against eccentric exercise and restoration of muscle force generation (27) . Our data suggests that assessment of skipping percentages via qPCR, especially for an exon nearer the 5' end of the dp427 transcript (such as exon 23) might prove less informative than expected: values expressed as a ratio provide no information regarding absolute numbers, and while successfully skipped transcripts will certainly give rise to mature dp427 mRNAs (unlike unskipped, which will promptly be degraded), even in healthy muscle, mature mRNA represents only ~20% of total dp427; the majority of the dp427 measured (skipped or unskipped) will be in the form of nascent rather than mature transcripts.
Conversely, labelling these muscles using our RNAscope probes does not permit assessment of skipping percentages, but instead allows both quantification of mature transcripts and estimation of total transcript numbers. While only a single muscle at each dose was examined, as we show here, 6mg.kg -1 treated muscle was indistinguishable from untreated mdx, while muscle treated with 12.5mg.kg -1 PPMO showed sarcoplasmic dp427 mRNA counts comparable to those of WT muscle. Our data suggests RNAscope in-situ methods can also reveal changes in transcriptional dynamics: counts of nuclei per field in 12.5mg.kg -1 PPMO treated muscle were comparable to untreated mdx while the fraction of nuclei with large 5' foci was comparable to healthy muscle (i.e. total numbers were higher than WT), suggesting that even without 100% skipping efficiency, treated muscles might achieve physiological levels of mature dp427 by producing supra-physiological levels of nascent transcripts. Fluorescence intensity of nuclear 5' foci was also increased over untreated mdx, implying that restoration of dystrophin contributes to the feed-forward mechanism, driving myofibre commitment and enhanced dp427 expression. This analysis raises a number of questions, however: in mice skipped transcripts are typically detectable within a week of systemic treatment, but a study following long-term response to exon skipping treatment in the mdx mouse (63) reported a 2-3 week lag between first detection of skipped transcripts and restoration of dystrophin protein, and further showed that both skipped dp427 transcripts and particularly dystrophin protein itself persisted for some weeks following the cessation of treatment. Levels of skipped transcripts and dystrophin protein in this study were low (~10% and 1-3% of WT respectively) but these data nevertheless suggest that the mean lifespan of dystrophin protein is of the order of days to weeks, and moreover that protein turnover is comparatively slow. It is hard to reconcile this with the mRNA dynamics revealed by our studies here (and those reported historically (16) ): despite a lengthy transcription time, mRNA turnover of dp427 appears to be remarkably rapid. Tissue persistence of antisense oligonucleotides was observed to decline in line with falling skipping percentages (63) (a process ostensibly compatible with ongoing skipping of short-lived dp427 mRNAs), the high stability of the dystrophin protein and the fact that this protein represents only a relatively minor component of the muscle protein milieu (14) seems incompatible with such dynamic transcript behaviour.
The implication is that in healthy muscle, dp427 mRNA molecules may be actively degraded despite having contributed essentially no dystrophin protein beyond the first post-export pioneering ribosomal proof-read.
If correct, this surprising finding might in fact be of considerable value to therapeutic approaches for DMD such as gene editing: if under healthy conditions many more transcripts are produced than are needed, in dystrophic conditions, beneficial levels of dystrophin protein might be restored with only modest levels of genomic correction (and studies suggest this may be the case (64) (65) (66) (67) (68) ).
Concluding remarks
The work shown here validates a novel use of RNAscope methodology, demonstrating the value of and this tissue is of key disease relevance (indeed our approach can be used to assess therapeutic efficiency).
There is no a priori reason why studies of dystrophin expression need be restricted to muscle however, and this latter consideration merits further clarification. The dystrophin gene is remarkable in that a single (admittedly enormous) gene gives rise to multiple mature mRNAs (and thus multiple protein isoforms) that are not splice variants, but 5' truncated sequences arising from different internal promoters. Moreover, expression of these isoforms (full length dp427, dp260, dp140, dp116 and dp71) is regulated in a highly tissue-specific fashion, suggesting that these truncated proteins all serve key functional roles. The shared sequence identity both at mRNA and protein level makes resolution of individual isoforms challenging, and spatiotemporal resolution within a given tissue is essentially impossible by conventional approaches. The ability to bind ISH probes to specific sequences within the dystrophin gene in a multiplex fashion offers a means to achieve just such spatiotemporal resolution. We have used two probes here: one to 5' sequence (exons 2-10), and one to 3' (exons 63-74). As shown, full length dystrophin (dp427) binds both probes, and the fluorophore signals are found in very close proximity. Moreover, nuclei expressing full-length dystrophin are rendered obvious by virtue of the high levels of 5' probe binding to nascent dp427 transcripts: expression of dp427 can be detected very clearly. A corollary of this is that robust 3' probe signal in the absence of matching adjacent 5' signal must therefore correspond to dp260, dp140 or dp71 ( Figure 1 ): these probes potentially allow in-situ discrimination of different dystrophin mRNA isoforms.
RNAscope offers multiplexing beyond 2 probes: 3 or even 4 probe channels are feasible. Given the potentially widespread expression profiles of dp140 and dp71 (4, 6, 47) (dp260 is believed to be largely retina-restricted (3)), a logical choice for a third probe would be one capable of distinguishing dp140 from dp71 (for example, binding to exons45-55). A triplet of probes (5', middle, 3') would allow extremely high resolution of multiple dystrophin isoforms: dp427 would show all 3 probes in close association, dp140 would show only 2, and dp71 would label with the 3' probe alone. Such a probe set might allow the intricacies of systemic dystrophin expression during neonatal development to be resolved, or allow the unique distribution of dystrophin isoforms within the brain to be mapped down to subcellular levels. Indeed, while the current therapeutic focus is on skeletal muscle, the brain is also known to be affected by dystrophin mutations: if treatment of skeletal muscle continues along current encouraging lines, the brain might be the next major therapeutic target, and the in situ hybridization methodology described here offers a powerful tool to aid such investigations. Scale bar: 100µm (subdivisions: 10µm). Table 1 : Mean per-image 5' and 3' particle counts for the eight quadriceps muscles used in this study All counts expressed as total, or subdivided by size (all foci 0.5-10μm 2 were classed as 'small', all those >10μm 2 as 'large'). Values shown are means ± standard deviations derived from 9-30 separate 20x images per muscle. Total and 'small' counts were significantly greater in WT muscle than dystrophic, while 'large' counts were not (P<0.05, Mann-Whitney U test). All mean values are shown graphically in figure 5A and C. (B) Distribution of distances between 5' and 3' sarcoplasmic foci. X-axis: distance between a given small 5' sarcoplasmic signal and the nearest 3' (or vice versa) in microns, Y-axis: fraction of total foci paired within that distance for WT (upper panels) and mdx (lower panels) quadriceps muscle. Left hand side: 5'-3'
Table and Figure Legends
distances are represented as green bars, 3'-5' distances as magenta (bars = means+SEMs, N=4). 40% of WT and 10% of mdx foci co-localize within 1 micron while <1% of WT and >30% of mdx foci are more than 30μm from a focus of the opposite probe. Dotted traces represent expected mean distributions for 200-1400 random points (as indicated). Right hand side: fractional distribution of all distances >= 1 micron. Both WT (mean: ~800 foci per image) and mdx (mean: ~200) show a higher fraction of 5'-3' pairings (or the reverse) below 8μm than would be expected. Lower panels: numbers and distributions of 5' and 3' foci in PPMO treated muscles. WT and untreated mdx values are from figure 5. Treatment with 12.5mg.kg -1 restores small sarcoplasmic dystrophin counts to near-WT levels but also increases total nuclear counts of all foci. Figure 10 : Dystrophin transcriptional dynamics revealed by RNAscope
In WT muscle myonuclei, RNA polymerases are loaded onto the transcriptional start site of the dystrophin locus faster than transcripts can be completed, resulting in a steady 'train' of polymerases and nascent transcripts, and leading to high nuclear concentrations of dp427 5' sequence. Dp427 3' sequence is completed only ~15 minutes before transcript completion and export, thus is present at much lower levels within the nucleus. Mature dp427 mRNAs, validated by the pioneer round of translation and carrying both 5' and 3' sequence, are found distributed throughout the sarcoplasm but are eventually degraded. In mdx muscle myonuclei, transcriptional initiation events are less frequent, leading to fewer nascent 5' sequences within nuclei, and the presence of a PTC (red crosses) within the dp427 transcript leads to prompt postexport mRNA degradation via the NMD pathway. Table 1 
